FormFactor, Inc.

NASDAQ:FORM

Semiconductors

Technology
$83.03 -0.21%

-$0.29 today

Market cap
$6.51B
Beta
1.26
P/E (TTM)
159.4
EPS (TTM)
$0.88
52W Low $26.08High $159.09

Volume 1.30M

Average 1.85M

Financial health

FormFactor, Inc. financial health

Start with the overall verdict and the rule-based risk checks for FORM, then work through liquidity, debt, balance-sheet quality, and claims on cash.

Financial health snapshot

Resilient

Debt service and balance sheet cushion look healthy, even if some working-capital ratios deserve context.

Cash and investments cover debt Healthy short-term liquidity Moderate leverage

Cash & Investments

$465.88M

Debt Cushion

$438.12M

Current Ratio

3.7x

Interest Coverage

N/A

Risk checks

0 of 11 flagged

  • Positive equity

    Positive

    Passes when: Shareholders' equity is above zero

  • Interest covered

    1193.1×

    Passes when: Operating income is at least 1.5× interest expense

  • Short-term liquidity

    3.7×

    Passes when: Current assets are at least 1× current liabilities

  • Near-term debt covered

    340.6×

    Passes when: Cash and short-term investments cover debt due within 12 months

  • Manageable net debt

    Net cash

    Passes when: Net debt is below 3× EBITDA

  • Debt repayable from cash flow

    0.2 yrs

    Passes when: Free cash flow could repay all debt within 5 years

  • Debt growth in line with sales

    -3.8% vs 1.6%

    Passes when: 3-year debt growth is no more than 5 points above revenue growth

  • Tangible equity base

    19.4%

    Passes when: Goodwill and intangibles are below 50% of equity

  • Stable Altman Z-Score

    12.23 → 15.69

    Passes when: Z-Score is not falling while below the 2.99 safe zone

  • Contained stock compensation

    13.8%

    Passes when: Stock-based compensation is below 20% of operating cash flow

  • Limited dilution

    -0.2%/yr

    Passes when: Diluted share count grows less than 2% a year

Financial strength scores

How strong are the fundamentals over time?

Piotroski tests profitability, balance-sheet direction, and efficiency; Altman estimates bankruptcy risk. Compare the current scores with their fiscal-year history.

Financial strength scores

Piotroski F-Score and Altman Z-Score from the latest reported financials

Piotroski F-Score

Average

7 / 9

Nine pass/fail tests of profitability, balance-sheet strength, and efficiency. 8–9 is strong, 0–3 is weak.

Altman Z-Score

Safe zone

17.49

Bankruptcy-risk model. Above 2.99 is the safe zone, 1.81–2.99 the grey zone, and below 1.81 the distress zone.

Score history

Piotroski F-Score and Altman Z-Score recalculated from each fiscal year's statements and year-end market value.

Liquidity

Can it meet short-term obligations?

Check whether cash and current assets cover what falls due within a year without depending on fresh financing.

Cash & Equivalents

$138.18M

Q3 2026

3Y +10.2%1Y +25.9%

Quick Ratio

3.0x

Q3 2026

Current Ratio

3.7x

Q3 2026

Cash Ratio

0.7x

Q3 2026

Working capital

How quickly does cash come back?

Receivable, inventory, and payable days show how much cash the operating cycle ties up and whether that is changing.

Working capital and cash conversion

Annual days measures from year-end receivables, inventory, and payables against revenue and cost of revenue.

Leverage

How much debt risk sits on the balance sheet?

Review total borrowings, debt relative to equity and assets, and whether operating profit covers interest costs.

Total Debt

$27.76M

Q3 2026

3Y -14.8%1Y -7.2%

Debt/Equity

0.0x

Q3 2026

Debt/Assets

0.0x

Q3 2026

Interest Coverage

—

Q3 2026

Debt service

Can cash flow carry the debt?

Measure debt against EBITDA and free cash flow, see how much is due within 12 months, and follow debt and cash over time.

Debt service capacity

Can operating cash flow carry the debt, and how much is due soon?

Debt and cash over time

Fiscal-year-end borrowings against liquid assets; net debt below zero means net cash.

Balance sheet cushion

How much room is there if conditions weaken?

Extra cash and investments, and the balance of assets against liabilities, give the company room when trading gets harder.

Long-Term Investments

$70.47M

Q3 2026

Assets

$1.43B

Q3 2026

3Y +5.4%1Y +6.6%

Liabilities

$250.42M

Q3 2026

3Y +9.8%1Y +8.3%

Balance sheet quality

Who funds the assets, and how tangible is the equity?

Split the claims on assets between suppliers, lenders, customers, and shareholders, and see how much equity rests on goodwill and intangibles.

Balance sheet quality

Who funds the assets, and how much of the equity is tangible (Q3 2026).

Shareholder claims

What do shareholders take out of the cash?

Dilution, stock-based pay, dividends, and buybacks all draw on cash flow; check whether free cash flow funds them.

Shareholder claims on cash

Dilution, stock-based pay, and whether free cash flow funds what is returned to shareholders.

Diluted shares, yearly change

-0.2%

FY2020–FY2025 compound rate

Stock-based compensation

$35.43M

13.8% of operating cash flow

Dividends paid

None

TTM to Q3 2026

Dividend / free cash flow

—

Above 100% means dividends exceed free cash flow

Buybacks

$9.24M

TTM to Q3 2026

Weighted diluted shares outstanding

Competitor health

How does FormFactor, Inc. compare with peers?

Compare leverage, interest coverage, and liquidity ratios with similar companies.

Competitor Health

Peer financial health comparison

CompanyMarket CapD/ED/AssetsND/EBITDAInt. Cov.QuickCurrentCash

Teradyne, Inc.

TER:NASDAQ

$38.96B0.120.080.0794.951.411.760.27

Cohu, Inc.

COHU:NASDAQ

$2.06B0.420.26Net cash—5.696.882.08

Aehr Test Systems

AEHR:NASDAQ

$1.87B0.050.0412.98—8.0110.336.52

inTEST Corporation

INTT:AMEX

$176.24M0.160.110.68—1.322.200.40

Questions

Financial health questions

Common questions about FORM's balance sheet, answered from the reported figures.

Is FORM's balance sheet healthy?

FormFactor, Inc. (FORM) has a current ratio of 3.68, a quick read on short-term liquidity.

How leveraged is FORM?

Debt to equity is 0.02, which helps judge how much financing risk sits on the balance sheet.